Pasithea Therapeutics Corp (KTTA)

$0.67 0.03 (3.87%)

15:54 EST KTTA Stock Quote Delayed 30 Minutes

KTTA Stock Alert: 6 Things to Know About Pasithea Therapeutics as Shares Soar Today

By William White, InvestorPlace Writer Dec 23, 2021

Pasithea Therapeutics (KTTA) stock is heading higher on heavy trading Thursday even without any recent news from the biotech company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 124,220

Day's Range $0.66 - $0.73

52-Week Range $0.54 - $1.54

Dividend & Yield N/A (N/A)

KTTA Stock Predictions, Articles, and Pasithea Therapeutics Corp News

From InvestorPlace
From the Web

KTTA Stock: The Depression Nasal Spray News That Has Pasithea Therapeutics Investors Ecstatic Today

By William White, InvestorPlace Writer Nov 23, 2021

Pasithea Therapeutics (KTTA) stock is rocketing higher on Tuesday after adding esketamine nasal spray to its U.K. offerings.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Nov 18, 2021

Good morning, investor! We're getting right into the thick of it today with a look at the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Oct 28, 2021

Good morning, investor! We're kicking off Thursday with a dive into the biggest pre-market stock movers traders will want to watch today!

Stocks That Hit 52-Week Lows On Tuesday

From Benzinga May 17, 2022

On Tuesday, 123 stocks made new 52-week lows.

Pasithea Biotech Reports That It's Aiming To Be At The Forefront Of The Mental Health Revolution

From Benzinga Apr 25, 2022

Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Virtual Reality Technologies Are Reportedly Unlocking New Possibilities For Mental Healthcare

From Benzinga Apr 18, 2022

Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Pasithea Reveals Cash Position Of $52.9 Million In Latest Earnings Report, To Expand Pipeline And Fund Operations Well Into 2024

From Benzinga Apr 1, 2022

Image sourced from Pixabay

This Ketamine-Assisted Therapy Company Is Developing New Ways To Treat Alcohol Addiction

From Benzinga Mar 24, 2022

Picture credit: Martin Sanchez on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

From Benzinga Mar 15, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) stock moved upwards by 92.3% to $44.04 during Tuesday's pre-market session. The market value of their outstanding shares is...

Pasithea Therapeutics Corp (KTTA)

KTTA Stock Alert: 6 Things to Know About Pasithea Therapeutics as Shares Soar Today

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Pasithea Therapeutics Corp (KTTA)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

KTTA Stock Predictions, Articles, and Pasithea Therapeutics Corp News

Subscriber Sign in